Accessibility Menu
Ibex Technologies logo

Ibex Technologies

(OTC) IBXNF

This security has been delisted. This page is retained for historical reference.

Ibex Technologies last closing stock price
MetricPriceDate
Last closeUSD 1.002024-04-05
Ibex Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.54%USD 1.072024-03-11
1 month-5.71%USD 1.062024-03-04
3 month+16.28%USD 0.862024-01-02
Year to date+16.28%USD 0.862023-12-27
1 year+78.57%USD 0.562023-03-28
3 year+270.37%USD 0.272021-04-06
5 year+699.36%USD 0.132019-03-13
Since inception+960.45%USD 0.092013-08-14

IBXNF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

IBXNF Financials

Key Financial Metrics (TTM)

Gross Margin

69.41%

Operating Margin

-19.76%

Net Income Margin

51.97%

Return on Equity

33.34%

Return on Capital

-9.71%

Return on Assets

23.13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

CA$5.77M

Operating Income

-CA$1.40M

EBITDA

CA$3.25M

Operating Cash Flow

CA$2.53M

Capital Expenditure

-CA$752.31K

Free Cash Flow

CA$1.78M

Cash & ST Invst.

CA$8.69M

Total Debt

CA$1.57M

Ibex Technologies Performance Analysis

Ibex Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-07-31CAD 4,163,866N/A
20222022-07-31CAD 6,217,84549.3%
20232023-07-31CAD 5,583,331-10.2%
Ibex Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-04-3031.5%
Q42023-07-31-22.5%
Q12023-10-3117.4%
Q22024-01-31-6.6%
Ibex Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-07-31CAD 0.02N/A
20222022-07-31CAD 0.05120.3%
20232023-07-31CAD 0.12120.5%
Ibex Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32023-04-30800.0%
Q42023-07-31149.4%
Q12023-10-31-63.4%
Q22024-01-31-93.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

CA$1.92M

+11.6%

Gross Profit

CA$1.37M

+17.9%

Gross Margin

71.24%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

CA$49.66K

-50.4%

EBITDA

CA$314.39K

+36.8%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

CA$8.69M

+16.1%

Total Debt

CA$1.57M

-0.1%

Accounts Receivable

CA$1.47M

+41.0%

Inventory

CA$253.67K

+18.3%

Long Term Debt

CA$1.31M

-3.4%

Short Term Debt

CA$260.84K

+20.5%

Return on Assets

23.13%

N/A

Return on Invested Capital

-9.85%

N/A

Free Cash Flow

CA$157.25K

+126.4%

Operating Cash Flow

CA$200.38K

+289.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IGXTIntelGenx Technologies Corp.
$0.17+0.00%
OCELOrganicell Regenerative Medicine, Inc.
$2.74-0.27%
GENHGeneration Hemp, Inc.
$0.22+0.00%
VBIOValion Bio, Inc.
$0.49+8.29%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
PATHUiPath
$12.03+0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.